{"id":"https://openalex.org/W7110643541","doi":null,"title":"Advances in the pathogenesis of hidradenitis suppurativa: new therapeutic targets and emerging treatments","display_name":"Advances in the pathogenesis of hidradenitis suppurativa: new therapeutic targets and emerging treatments","alternate_titles":[],"publication_year":2025,"publication_date":"2025-05-01","ids":{"openalex":"https://openalex.org/W7110643541"},"language":"es","primary_location":{"id":"pmh:oai:repositorio.unican.es:10902/37345","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10902/37345","pdf_url":null,"source":{"id":"https://openalex.org/S4306400398","display_name":"UCrea (University of Cantabria)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13134134","host_organization_name":"Universidad de Cantabria","host_organization_lineage":["https://openalex.org/I13134134"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/bachelorThesis"},"parent_works":[],"lineage":["https://openalex.org/W7110643541"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hdl.handle.net/10902/37345","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Santiago Seti\u00e9n, \u00c1ngel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Santiago Seti\u00e9n, \u00c1ngel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12731","display_name":"Hidradenitis Suppurativa and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12731","display_name":"Hidradenitis Suppurativa and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12328","display_name":"Autoimmune and Inflammatory Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13328","display_name":"Osteomyelitis and Bone Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hidradenitis-suppurativa","display_name":"hidradenitis suppurativa","score":1.0},{"id":"https://openalex.org/keywords/pathogenesis","display_name":"pathogenesis","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.8600000143051147},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9610000252723694},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.9580000042915344},{"id":"https://openalex.org/keywords/il-36","display_name":"IL-36","score":0.9900000095367432},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":1.0},{"id":"https://openalex.org/keywords/adipokines","display_name":"adipokines","score":0.9959999918937683},{"id":"https://openalex.org/keywords/complement-system","display_name":"complement system","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":0.9990000128746033},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.9259999990463257},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.9760000109672546},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":1.0},{"id":"https://openalex.org/keywords/bimekizumab","display_name":"bimekizumab","score":1.0},{"id":"https://openalex.org/keywords/anti-il-1-therapy","display_name":"anti-IL-1 therapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8209999799728394},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8185999989509583},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.8144000172615051},{"id":"https://openalex.org/C2776002364","wikidata":"https://www.wikidata.org/wiki/Q341999","display_name":"Hidradenitis suppurativa","level":3,"score":0.7164999842643738},{"id":"https://openalex.org/C2777645581","wikidata":"https://www.wikidata.org/wiki/Q1671433","display_name":"Intertriginous","level":3,"score":0.6801999807357788},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6177999973297119},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4706999957561493},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41929998993873596},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.38679999113082886},{"id":"https://openalex.org/C2992264114","wikidata":"https://www.wikidata.org/wiki/Q1394551","display_name":"Clinical disease","level":3,"score":0.30219998955726624},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.2831999957561493},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.25130000710487366}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:repositorio.unican.es:10902/37345","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10902/37345","pdf_url":null,"source":{"id":"https://openalex.org/S4306400398","display_name":"UCrea (University of Cantabria)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13134134","host_organization_name":"Universidad de Cantabria","host_organization_lineage":["https://openalex.org/I13134134"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/bachelorThesis"}],"best_oa_location":{"id":"pmh:oai:repositorio.unican.es:10902/37345","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10902/37345","pdf_url":null,"source":{"id":"https://openalex.org/S4306400398","display_name":"UCrea (University of Cantabria)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13134134","host_organization_name":"Universidad de Cantabria","host_organization_lineage":["https://openalex.org/I13134134"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/bachelorThesis"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2944481320","https://openalex.org/W3021871401","https://openalex.org/W4376630266","https://openalex.org/W4200162681","https://openalex.org/W4220871749","https://openalex.org/W3098610466","https://openalex.org/W7218636090","https://openalex.org/W3216963570","https://openalex.org/W3016201179","https://openalex.org/W2979875196"],"abstract_inverted_index":{"Hidradenitis":[0],"suppurativa":[1],"(HS)":[2],"is":[3,75],"a":[4,140],"chronic":[5],"inflammatory":[6],"disease":[7,60,175],"of":[8,16,32,47,54,68,73,80,92,111,142],"the":[9,14,24,38,45,52,59,71,78,90,98,109,116],"pilosebaceous":[10],"unit,":[11],"characterized":[12],"by":[13],"formation":[15],"painful":[17],"nodules,":[18],"abscesses":[19],"and":[20,82,85,101,135,166],"fistulous":[21],"tracts":[22],"in":[23,43,61,70,131,174],"intertriginous":[25],"areas":[26],"that":[27],"severely":[28],"impact":[29],"patients'":[30],"quality":[31],"life.":[33],"This":[34],"paper":[35],"systematically":[36],"reviews":[37],"scientific":[39],"literature":[40],"on":[41],"advances":[42],"understanding":[44],"pathogenesis":[46,72],"HS,":[48],"as":[49,51,87,89,96,115,161],"well":[50,88],"development":[53,110],"emerging":[55],"treatments":[56],"for":[57,121],"controlling":[58],"its":[62],"severe":[63,122],"forms.":[64],"The":[65],"central":[66],"role":[67],"cytokines":[69],"HS":[74,123],"analyzed,":[76],"highlighting":[77],"roles":[79],"TNF-\u03b1":[81],"IL-1\u03b2,":[83],"IL-36,":[84],"IL-17,":[86],"involvement":[91],"other":[93],"agents":[94],"such":[95,114,160],"adipokines,":[97],"complement":[99],"system,":[100],"neutrophils.":[102],"Understanding":[103],"these":[104,149],"pathogenetic":[105],"mechanisms":[106],"has":[107],"allowed":[108],"targeted":[112],"therapies,":[113],"biologic":[117],"drugs":[118],"currently":[119],"approved":[120],"(adalimumab,":[124],"secukinumab,":[125],"bimekizumab),":[126],"which":[127,169],"have":[128],"demonstrated":[129],"efficacy":[130],"both":[132],"clinical":[133,137],"trials":[134],"real-world":[136],"practice.":[138],"However,":[139],"percentage":[141],"patients":[143],"do":[144],"not":[145],"respond":[146],"adequately":[147],"to":[148],"treatments.":[150],"Therefore,":[151],"highly":[152],"promising":[153],"new":[154,164],"therapeutic":[155],"options":[156],"are":[157],"being":[158],"investigated,":[159],"anti-IL-1,":[162],"anti-IL-36,":[163],"anti-IL-17,":[165],"JAK":[167],"inhibitors,":[168],"may":[170],"offer":[171],"better":[172],"results":[173],"control.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7110643541","counts_by_year":[],"updated_date":"2026-09-11T09:22:31.653822","created_date":"2025-12-08T00:00:00"}
